Modifying the anti-inflammatory effects of high-density lipoprotein.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 57, doi. 10.1007/BF02693941
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2007 AND VI 9 AND IP 1
Results: 13
1
2
Will torcetrapib be the next big thing in coronary heart disease risk reduction?
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 48, doi. 10.1007/BF02693940
- By:
- Publication type:
- Article
3
Clinical trials report.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 45, doi. 10.1007/BF02693939
- By:
- Publication type:
- Article
4
Statins and biomarkers of inflammation.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 33, doi. 10.1007/BF02693938
- By:
- Publication type:
- Article
5
Statin therapy in cardiovascular diseases other than atherosclerosis.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 25, doi. 10.1007/BF02693937
- By:
- Publication type:
- Article
6
Statin therapy in renal disease: Harmful or protective?
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 18, doi. 10.1007/BF02693936
- By:
- Publication type:
- Article
7
Statin therapy: Is the percent reduction or the attained low-density lipoprotein cholesterol level more important?
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 10, doi. 10.1007/BF02693935
- By:
- Publication type:
- Article
8
Clinical trials report.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 5, doi. 10.1007/BF02693934
- By:
- Publication type:
- Article
9
Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 81, doi. 10.1007/BF02693933
- By:
- Publication type:
- Article
10
Squalene synthase inhibition: A novel target for the management of dyslipidemia.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 78, doi. 10.1007/BF02693932
- By:
- Publication type:
- Article
11
PPARδ agonists and metabolic diseases.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 72, doi. 10.1007/BF02693931
- By:
- Publication type:
- Article
12
Update on PPAR agonists: The clinical significance of FIELD and PROACTIVE.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 64, doi. 10.1007/BF02693930
- By:
- Publication type:
- Article
13
Are we victims of our own success in cardiovascular therapeutics?
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 1, p. 1, doi. 10.1007/BF02693929
- By:
- Publication type:
- Article